Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis

References

• Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995; 40: 173–196
   PubMed Web of Science ®Google Scholar
• Benson M D. Amyloidosis. The metbolic and molecular bases of inherited disease8th ed, C R Scriver, A L Beaudet, W S Sly, D Valle, B Childs, K W Kinzler, B Vogelstein. McGraw Hill Book Company, New York 2000; 5345–5378
   Google Scholar
• Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid J Protein Folding Disord 2003; 10: 160–184
   PubMed Web of Science ®Google Scholar
• Martone R L, Herbert J, Dwork A, Schon E A. Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 1988; 151: 905–912
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, Negi A, Ando M. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996; 62: 1037–1038
   PubMed Web of Science ®Google Scholar
• Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneropathy. Ann Intern Med 2001; 135: 931–932
   PubMed Web of Science ®Google Scholar
• Munar-Qués M, Salvá-Ladaria L, Mulet-Perera P, Solé M, López-Andreu F R, Saraiva M JM. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid Int J Exp Clin Invest 2000; 7: 266–269
   PubMed Web of Science ®Google Scholar
• Yazaki M, Liepnieks J J, Kincaid J C, Benson M D. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid. Muscle Nerve 2003; 28: 438–442
   PubMed Web of Science ®Google Scholar
• Dwulet F E, Benson M D. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest 1986; 78: 880–886
   PubMed Web of Science ®Google Scholar
• Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin E C. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–933
   PubMed Web of Science ®Google Scholar
• Schagger H, Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1–100 kDA. Anal Biochem 1987; 166: 368–379
   PubMed Web of Science ®Google Scholar
• Herbert J, Wilcox J N, Pham K -TC, Fremeau R T, Jr, Zeviani M, Dwork A, Soprano D R, Makover A, Goodman D S, Zimmerman E A, Roberts J L, Schon E A. Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 1986; 36: 900–911
   PubMed Web of Science ®Google Scholar
• Thylén C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 1993; 12: 743–748
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Ohlsson P -I, Olofsson A, Sandgren O, Suhr O, Terazaki H, Obayashi K, Lundgren E, Ando M, Negi A. Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met). Amyloid Int J Exp Clin Invest 1999; 6: 119–123
   PubMed Web of Science ®Google Scholar
• Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004; 77: 345–349
   PubMed Web of Science ®Google Scholar
• Felding P, Fex G, Westermark P, Olofsson B O, Pitkänen P, Benson L. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 1985; 21: 133–140
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Prelli F C, Wright J, Pras M, Frangione B. Systemic Senile Amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: Immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989; 83: 836–843
   PubMed Web of Science ®Google Scholar
• Bergström J, Gustavsson Å, Hellman U, Sletten K, Murphy C L, Weiss D T, Solomon A, Olofsson B -O, Westermark P. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005; 206: 224–232
   PubMed Web of Science ®Google Scholar
• Cornwell G G, III, Sletten K, Johansson B, Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 1988; 154: 648–653
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell G G, III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87: 2843–2845
   PubMed Web of Science ®Google Scholar
• Gustavsson Å, Jahr H, Tobiassen R, Jacobson D R, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995; 73: 703–708
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Olofsson B -O. Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy. Clin Exp Immunol 1987; 69: 695–701
   PubMed Web of Science ®Google Scholar
• Nordlie M, Sletten K, Husby G, Ranløv P J. A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand J Immunol 1988; 27: 119–122
   PubMed Web of Science ®Google Scholar
• Hermansen L F, Bergman T, Jörnvall H, Husby G, Ranløv I, Sletten K. Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy. Eur J Biochem 1995; 227: 772–779
   PubMedGoogle Scholar
• Wallace M R, Dwulet F E, Conneally P M, Benson M D. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 1986; 78: 6–12
   PubMed Web of Science ®Google Scholar
• Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S -I. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant Wild-type transthyretin. Biochem Biophys Res Commun 2000; 274: 702–706
   PubMed Web of Science ®Google Scholar
• Blake C CF, Geisow M J, Oatley S J. Structure of prealbumin: secondary, tertiary, and quaternary interactions determined by fourier refinement at 1·8 Å. J Mol Biol 1978; 121: 339–356
   PubMed Web of Science ®Google Scholar
• Hamilton J A, Steinrauf L K, Braden B C, Murrell J R, Benson M D. Structural changes in transthyretin produced by the Ile84Ser mutation which result in decreased affinity for retinol-binding protein. Amyloid Int J Exp Clin Invest 1996; 3: 1–12
   Web of Science ®Google Scholar
• Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoasparteate and its repair system. Biol Pharm Bull 2005; 28: 1590–1596
   PubMed Web of Science ®Google Scholar
• Robinson N E, Robinson A B. Molecular clocks. Proc Natl Acad Sci USA 2001; 98: 944–949
   PubMed Web of Science ®Google Scholar
• Hanes D, Zech L A, Murrell J, Benson M D. Metabolism of Normal and Met30 Transthyretin. Advances in Food and Nutrition Research, S P Coburn, D W Townsend. Academic Press, San Diego 1996; 40: 149–155
   Google Scholar